author-photo

Kerry D. Fisher

University of Oxford

124

Papers

3214

Citations

Citation Trend

Filter By

Papers (92) Sort By

Journal Conference Others

Polymer Stealthing and Mucin-1 Retargeting for Enhanced Pharmacokinetics of an Oncolytic Vaccinia Virus

2021 Molecular Therapy - Oncolytics
Show All
- Source
- Cite
- Save
Citations (0)
Tackling HLA Deficiencies Head on with Oncolytic Viruses.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (4)
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (7)
The role of cancer metabolism in defining the success of oncolytic viroimmunotherapy

2020 Cytokine & Growth Factor Reviews
Show All
- Source
- Cite
- Save
Citations (1)
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR).

2020 Radiation Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo

2019 Bioconjugate Chemistry
Show All
- Source
- Cite
- Save
Citations (9)
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (32)
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators

2017 Molecular Therapy - Oncolytics
Show All
- Source
- Cite
- Save
Citations (32)
47POptimizing the tolerability of intravenous oncolytic viral immunotherapy administration: A sub-analysis of tolerability and cytokine data from the EVOLVE study of enadenotucirev (EnAd), an oncolytic adenovirus

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

2017 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (72)